Exelixis Inc. (EXEL) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 8:55 PM

Exelixis Inc. (EXEL) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on EXEL
Apple, Tesla hit intraday records; Possible breach at Home Depot 2:15 p.m. Sept. 2, 2014 - Angela Johnson
Exelixis shares plunge 55% after disappointing trial results 8:40 a.m. Sept. 2, 2014 - Tomi Kilgore
Biotechs still sliding, but Wall Street says don't hit panic button just yet 1:43 p.m. March 26, 2014 - Russ Britt
HMA’s pre-emptive strike against ‘60 Minutes’ 4:44 p.m. Nov. 30, 2012 - Russ Britt
Chipotle vs. Taco Bell: testing Einhorn's thesis 5:37 a.m. Oct. 4, 2012 - The Trading Deck
Exelixis prices stock offering at 0.7% discount 11:21 a.m. Aug. 9, 2012 - MarketWatch.com
Exelixis slides 12% on stock, debt offering 2:39 p.m. Aug. 6, 2012 - Val Brickates Kennedy
FDA to speed Exelixis thyroid-cancer-drug review 5:35 a.m. July 30, 2012 - MarketWatch.com
Stocks to watch Thursday: GM, Agilent, NetApp 6:51 a.m. Feb. 16, 2012 - MarketWatch
Exelixis licenses cancer-drug R&D to Merck & Co. 7:26 a.m. Dec. 21, 2011 - MarketWatch.com
Loathe that investment theme? Perfect! 12:03 p.m. Nov. 8, 2011 - The Trading Deck
Exelixis plunges on drug study woes 11:05 a.m. Nov. 1, 2011 - Val Brickates Kennedy
Stocks to watch Tuesday: Exelixis, DirecTV, Leap 5:46 a.m. Nov. 1, 2011 - MarketWatch
Exelixis slides, Allstate up in after-hours trade 5:48 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis shares fall without FDA study commentary 5:05 p.m. Oct. 31, 2011 - Wallace Witkowski
Exelixis shares resume trading, drop 35% 4:44 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis rallies 21% on drug study 10:46 a.m. Oct. 24, 2011 - Val Brickates Kennedy
Icahn reports new stakes in Vector Group, El Paso 6:52 p.m. Aug. 15, 2011 - MarketWatch.com
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:50 p.m. June 6, 2011 - Kate Gibson

Other News on EXEL
Exelixis: Why This Company Could Become The Next Dendreon 12:54 p.m. Nov. 18, 2014 - Seeking Alpha
Update: Exelixis Announces Very Positive Phase 1 Trial Data 1:28 a.m. Nov. 18, 2014 - Seeking Alpha
Biotech Weekly: Here Come The Institutional Holdings Updates 8:31 a.m. Nov. 17, 2014 - Seeking Alpha
Update: Exelixis Reports Q3 Earnings - Impact To My Thesis 4:42 a.m. Nov. 7, 2014 - Seeking Alpha
Exelixis completes enrollment in cabozantinib Phase 3 7:31 a.m. Nov. 6, 2014 - Seeking Alpha
Exelixis' (EXEL) CEO Mike Morrissey on Q3 2014 Results - Earnings Call Transcript 10:42 p.m. Nov. 4, 2014 - Seeking Alpha
Exelixis (EXEL) Q3 2014 Results - Earnings Call Webcast 4:55 p.m. Nov. 4, 2014 - Seeking Alpha
10-Q: EXELIXIS, INC. 4:05 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Tuesday's close 5:35 p.m. Nov. 3, 2014 - Seeking Alpha
Will Exelixis (EXEL) Disappoint This Earnings Season? - Analyst Blog 2:35 p.m. Nov. 3, 2014 - Zacks.com
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 1:53 p.m. Oct. 3, 2014 - Seeking Alpha
Roche Presents Data on Cancer Immunotherapy Candidate - Analyst Blog 9:50 a.m. Oct. 3, 2014 - Zacks.com
Exelixis (EXEL) Is in Oversold Territory: What's Next? - Tale of the Tape 9:41 a.m. Oct. 3, 2014 - Zacks.com
Update: Exelixis Announces Very Positive Results From The CoBRIM Trial - Impacts To My Bull Thesis 9:57 a.m. Sept. 29, 2014 - Seeking Alpha
Exelixis up on clinical trial results 7:38 a.m. Sept. 29, 2014 - Seeking Alpha
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. 7:41 p.m. Sept. 28, 2014 - GuruFocus.com
Why Exelixis (EXEL) Stock Might be a Great Pick - Tale of the Tape 8:53 a.m. Sept. 18, 2014 - Zacks.com
Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick 8:38 a.m. Sept. 16, 2014 - Seeking Alpha
Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious 8:41 a.m. Sept. 15, 2014 - Seeking Alpha
Exelixis' (EXEL) CEO Michael Morrissey Presents at Morgan Stanley Healthcare Conference (Transcript) 6:04 p.m. Sept. 9, 2014 - Seeking Alpha

Press Releases on EXEL
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Exelixis Announces PositivePreliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib 4:20 a.m. Nov. 16, 2014 - BusinessWire - BZX
Exelixis to Present at theStifel2014Healthcare Conference on Tuesday, November 18 4:40 p.m. Nov. 11, 2014 - BusinessWire - BZX
Exelixis CompletesEnrollment of the METEOR Phase 3 Pivotal Trial of Cabozantinib in Metastatic Renal Cell Carcinoma 6:04 a.m. Nov. 6, 2014 - BusinessWire - BZX
Exelixis Announces Positive Top-Line Results From a Phase 2 Trial of Cabozantinib and Erlotinib in Patients With EGFR Wild-Type Non-Small Cell Lung Cancer 4:14 p.m. Nov. 4, 2014 - BusinessWire - BZX
Exelixis Announces Third Quarter 2014 Financial Results and Provides Corporate Update 4:13 p.m. Nov. 4, 2014 - BusinessWire - BZX
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 8:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Exelixis to Release Third Quarter 2014 Financial Results on Tuesday, November 4, 2014 3:12 p.m. Oct. 14, 2014 - BusinessWire - BZX
Exelixis Announces Positive Results from Phase 3 Pivotal Trial ofCobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma 2:00 a.m. Sept. 29, 2014 - BusinessWire - BZX
Exelixis Announces Cobimetinib Phase3coBRIM Results toBePresented at ESMO 2014 Congress 12:00 a.m. Sept. 17, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Exelixis to Present at theMorgan Stanley Global Healthcare Conference on Tuesday, September 9 3:05 p.m. Sept. 8, 2014 - BusinessWire - BZX
Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trialof Cabozantinib in Men with MetastaticCastration-ResistantProstate Cancer 5:00 p.m. Sept. 1, 2014 - BusinessWire - BZX
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Exelixis Announces Second Quarter 2014 Financial Results 3:14 p.m. July 31, 2014 - BusinessWire - BZX
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 8:20 a.m. July 31, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 7:40 a.m. July 29, 2014 - PR Newswire - PRF
SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead 7:40 a.m. July 18, 2014 - PR Newswire - PRF
Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2:05 p.m. July 17, 2014 - PR Newswire - PRF
Exelixis to Release Second Quarter 2014 Financial Results on Thursday, July 31, 2014 3:06 p.m. July 16, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SimpliTrain's Momentum in LMS Market Heating Up

SimpliTrain Finds its Groove in the LMS Arena Out here in Delray Beach, SimpliTrain's making waves in the Learning Management System (LMS) market, recently snagging the 'Pervasive Player' tag from MarketsandMarkets' 360Quadrants platform. This cloud-based learning powerhouse ain't just playing around; they're doubling down with expansion into AI and other fancy tech bits...

ASU Teams Up for National Manufacturing Workforce Push

ASU's Role in Reviving American Manufacturing The Foundry School is a big hit for Arizona State University (ASU) as it joins hands with seven other top-tier universities under the U.S. Departments of State and Labor's initiative. This project is all about sculpting the future players of American manufacturing. In a scene highlighted by the Vice President and girded by...

Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

AARP New York Promotes Affordable 'Staycation' Experiences

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

Tetragon Completes $50M Tender Offer; Shares Prorated

Unpacking Tetragon’s $50 Million Dutch Auction Move If you comb through the smoke-filled corridors of finance, you'll find the name Tetragon Financial Group pacing the latest tender offer rounds. They danced their way through a $50 million 'modified Dutch auction,' snapping up non-voting shares with a kind of ruthless efficiency that only seasoned market players can...

Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout

Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...

Woodland Direct Expands West with Reno Facility

Woodland Direct Takes a Bold Step Westward It's no small feat when a company's growing pains turn into growing gains, yet that's exactly what Woodland Direct has managed to pull off with their latest expansion strategy. The Auburn Hills-based e-commerce juggernaut, synonymous with high-quality fire products, just cut the ribbon on a sparkling new 47,000-square-foot...

Megan Holdings Investors Face Deadline for Class Action

Forgive my bluntness, but if you've been snoozing on your Megan Holdings Limited (NASDAQ:MGN) shares, it's time to wake up and smell the lawsuit papers. They're flying around faster than news at a market crash. If you snagged those shares between September 26, 2025, and March 25, 2026, or got in during the IPO on September 26, 2025, here's the deal: the deadline looms on...

Pudu Robotics Showcases Expansive Portfolio at IFA 2026

Robotics in the Spotlight: Pudu's Grand European Entry Well, you don't see this every day—Pudu Robotics, a name riding high in the robotics sphere, is strutting its stuff over at IFA 2026 in Berlin. This ain't just a teaser, folks. They're unloading the whole toolkit, diving head-first into the European market. From gears turning in service delivery bots to industrial...

Powder River Crude's Open Season: Strategic Move

Powder River Crude Services Drives Into Wyoming Every now and then, a player's got to lay down their cards early, and Powder River Crude Services is doing just that with their open season announcement. Anyone keeping an eye on the crude oil transport game will want to watch how this proposed pipeline project unfolds. Slated to stretch from Converse County to Douglas,...